Modeling clonal evolution and oncogenic dependency in vivo in the context of hematopoietic transformation
Robert L. Bowman(University of Pennsylvania), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Inés Fernández-Maestre(Memorial Sloan Kettering Cancer Center), Linde A. Miles(Memorial Sloan Kettering Cancer Center), Shoron Mowla(Memorial Sloan Kettering Cancer Center), Martin Carroll(University of Pennsylvania), Michael R. Waarts(Cancer Services), Anthony R. Martinez Benitez(Memorial Sloan Kettering Cancer Center), Sara E. Meyer(Sidney Kimmel Cancer Center), Shira E. Eisman(Memorial Sloan Kettering Cancer Center), Wenbin Xiao(Memorial Sloan Kettering Cancer Center), Andrew Dunbar(Memorial Sloan Kettering Cancer Center), Chad R. Potts(Vanderbilt University Medical Center), Tanmay Mishra(Vellore Institute of Technology University), Nayla Boorady(Memorial Sloan Kettering Cancer Center), Isabelle Csete(Cancer Services), Jennifer J. Trowbridge(Jackson Laboratory), Louise Cai(Memorial Sloan Kettering Cancer Center), Matthew T. Jenkins(Vanderbilt University Medical Center), Sheng F. Cai(Memorial Sloan Kettering Cancer Center), Pablo Sánchez Vela(Memorial Sloan Kettering Cancer Center), Young Joo Park(Sutro Biopharma (United States)), P. Brent Ferrell(Vanderbilt University Medical Center), Darren Lee(University of Cincinnati Medical Center), Aishwarya Krishnan(Memorial Sloan Kettering Cancer Center)
Cited by 2
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k